- Regulation
- Technology
- Resources
Latest News
- Industry
Medicare
-
CMS presents shake-up for Medicare Advantage star ratings
The agency suggested dropping 12 quality measures of health plan performance and refocusing on aspects like patient experience.
-
Three faces of healthcare fraud: the billing practices that cost federal programs millions
Recent DOJ actions, including two Michigan pharmacy schemes and a nationwide wound care provider, show how different types of misconduct can thrive within the same reimbursement system.
-
CMS quietly rolls out new round of Medicare-negotiated drug prices
The second-cycle negotiated-price drugs include medicines to treat cancer, asthma, and metabolic conditions.
-
A sweep of enforcement: DOJ unveils four major fraud and national security actions
This is a set of significant cases involving healthcare fraud, securities manipulation, North Korean revenue operations, and a cryptocurrency Ponzi scheme.
-
White House, Eli Lilly, Novo Nordisk announce anti-obesity drug deals
The deals will open the Medicare market for these popular drugs to millions of Americans.